Christopher Peetz - Net Worth and Insider Trading

Christopher Peetz Net Worth

The estimated net worth of Christopher Peetz is at least $38 Million dollars as of 2026-09-12. Christopher Peetz is the CHIEF EXECUTIVE OFFICER of Mirum Pharmaceuticals Inc and owns about 381,940 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $38 Million. Christopher Peetz is also the Director of Alpine Immune Sciences Inc and owns about 1,900 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $123,443. Details can be seen in Christopher Peetz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Peetz has not made any transactions after 2026-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher Peetz

To

Christopher Peetz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Peetz owns 4 companies in total, including Mirum Pharmaceuticals Inc (MIRM) , Alpine Immune Sciences Inc (ALPN) , and Regado Biosciences Inc (RGDO) among others .

Click here to see the complete history of Christopher Peetz’s form 4 insider trades.

Insider Ownership Summary of Christopher Peetz

Ticker Company Transaction Date Type of Owner
MIRM Mirum Pharmaceuticals Inc 2026-09-01 director & President and CEO
ALPN Alpine Immune Sciences Inc 2021-09-23 director
RGDO Regado Biosciences Inc 2016-11-01 Chief Financial Officer
LIMIT LIMIT 2026-07-15 director

Christopher Peetz Latest Holdings Summary

Christopher Peetz currently owns a total of 2 stocks. Among these stocks, Christopher Peetz owns 381,940 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 1, 2026, with a value of $38 Million and a weighting of 99.67%. Christopher Peetz also owns 1,900 shares of Alpine Immune Sciences Inc (ALPN) as of September 23, 2021, with a value of $123,443 and a weighting of 0.33%.

Latest Holdings of Christopher Peetz

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2026-09-01 381,940 98.22 37,514,147
ALPN Alpine Immune Sciences Inc 2021-09-23 1,900 64.97 123,443

Holding Weightings of Christopher Peetz


Christopher Peetz Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Peetz has made a total of 21 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 20 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 30,000 shares on September 1, 2026, which brought Christopher Peetz around $3 Million.

According to the SEC Form 4 filings, Christopher Peetz has made a total of 2 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Alpine Immune Sciences Inc is the sale of 1,900 shares on September 23, 2021, which brought Christopher Peetz around $19,323.

Insider Trading History of Christopher Peetz

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Peetz Trading Performance

GuruFocus tracks the stock performance after each of Christopher Peetz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Peetz is 21.03%. GuruFocus also compares Christopher Peetz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Peetz within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Peetz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Peetz

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.1 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.1 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Christopher Peetz owns.
View MIRM Analysis

Christopher Peetz Ownership Network

Ownership Network List of Christopher Peetz

No Data

Ownership Network Relation of Christopher Peetz

Insider Network Chart


Christopher Peetz Owned Company Details

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Christopher Peetz is the director & President and CEO of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , CHIEF FINANCIAL OFFICER Eric Bjerkholt , and Chief Operating Officer Peter Radovich .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Christopher Peetz made 11 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 271,301. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 126,343 shares made by Jolanda Howe , a net sale of 29,180 shares made by Saira Ramasastry , and a net sale of 35,340 shares made by Eric Bjerkholt .

In summary, during the past 3 months, insiders sold 128,814 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 128,814 shares. During the past 18 months, 680,937 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 131,974 shares were bought by its insiders, resulting in a net sale of 548,963 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher Peetz Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Peetz. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher Peetz's mailing address is: Foster City Ca 94404.